뉴스
-
Onconic Surges on Jaqbo’s India Approval[K-Bio Pulse]
South Korea’s pharmaceutical and life sciences sectors advanced in tandem on Aug. 6, led by Onconic Therapeutics, Qurient and Voronoi.The pharmaceutical index gained 2.24%, with 97 of 161 stock...
www.edaily.co.kr · 2026.08.07
-
FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls...
On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed following a 5-for-1 reverse stock split...
www.edaily.co.kr · 2026.08.11
-
Korean investors flock to leveraged US ETFs, take another hit
The fund seeks to deliver three times the daily return of the Philadelphia... single-stock leveraged ETFs tied to Samsung Electronics and SK hynix.
www.koreatimes.co.kr · 2026.08.03
-
Will Investment Sentiment Return to Bio Amid Tech Adjustment? KM Pharmaceutical and Lemon Healthc...
As the domestic stock market recently enters a breathing spell focused on semiconductors and key Information
www.edaily.co.kr · 2026.07.31
-
Kosdaq Bio Rally...Alteogen Soars on European Patent Win [K-bio Pulse]
On July 23, the domestic stock market surged as artificial intelligence (AI) investment expectations combined with strong momentum in healthcare and biotechnology stocks.
www.edaily.co.kr · 2026.07.24
-
Chasing High Returns Despite Risks? Three "Problematic" Bio Stocks Land Among Top 15 Ga...
As the domestic stock market enters a correction phase, loose liquidity is flowing back into the pharmaceutical and bio sectors.
www.edaily.co.kr · 2026.07.21
-
US Stock Futures Steady Ahead of Tesla, Alphabet Earnings as Iran Conflic...
stock index futures traded little changed late Tuesday after Wall Street rallied on the back of... from Tesla and Alphabet.
www.econotimes.com · 2026.07.22
-
Mixed Market, Solid Footing: Psomagen and Jetema Stand Out [K-Bio Pulse]
While the domestic stock market has recently remained mixed and struggled to find a clear direction, the pharmaceutical and biotech sectors have carved out an upward trajectory.
www.edaily.co.kr · 2026.07.02
-
Lemon Healthcare Rebounds to Limit-Up on Second Trading Day; D&D Pharmatech, PharmaResearch Also ...
South Korea's pharmaceutical and biotech sector posted broad gains on Tuesday despite heightened market volatility that triggered a sell-side sidecar on the benchmark stock market early in the sessio...
www.edaily.co.kr · 2026.07.08
-
BL Pharmtech Shares Hit Upper Limit as Expectations Grow for Technology Transfer Deal[K-Bio Pulse...
On June 18, shares of BL PharmTech, JLK, and Raphas stood out in the domestic pharmaceutical and biotechnology stock market with strong gains.
www.edaily.co.kr · 2026.06.21
